| 2022 | Periodontal disease and cancer risk: A nationwide population-based cohort study
| FRONTIERS IN ONCOLOGY |
| 2013 | Personalized therapy on the horizon for squamous cell carcinoma of the lung | LUNG CANCER |
| 2015 | Phase II clinical and exploratory biomarker study of dacomitinib in patients with recurrent and/or metastatic squamous cell carcinoma of head and neck | CLINICAL CANCER RESEARCH |
| 2013 | Phase II study of camtobell inj. (belotecan) in combination with cisplatin in patients with previously untreated, extensive stage small cell lung cancer | LUNG CANCER |
| 2022 | Phase II study of gemcitabine with oxaliplatin (GEMOX) in heavily treated patients with advanced hepatocellular carcinoma after failure of sorafenib treatment (PEACH) | JOURNAL OF CLINICAL ONCOLOGY |
| 2020 | Pre-screening of patient-reported symptoms using the Edmonton Symptom Assessment System in outpatient palliative cancer care | EUROPEAN JOURNAL OF CANCER CARE |
| 2020 | Prognosis of Synchronous Colorectal Liver Metastases After Simultaneous Curative-Intent Surgery According to Primary Tumor Location and KRAS Mutational Status | ANNALS OF SURGICAL ONCOLOGY |
| 2024 | Protocol for cross-platform characterization of human and murine extracellular vesicles and particles
| STAR Protocols |
| 2013 | Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumors
| SUPPORTIVE CARE IN CANCER |
| 2022 | Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group
| CANCER RESEARCH AND TREATMENT |
| 2023 | Reprogramming anchorage dependency by adherent-to-suspension transition promotes metastatic dissemination
| MOLECULAR CANCER |
| 2021 | Role of Preoperative Chemoradiotherapy in Clinical Stage II/III Rectal Cancer Patients Undergoing Total Mesorectal Excision: A Retrospective Propensity Score Analysis
| FRONTIERS IN ONCOLOGY |
| 2023 | Spatial and clonality-resolved 3D cancer genome alterations reveal enhancer-hijacking as a potential prognostic marker for colorectal cancer
| CELL REPORTS |
| 2018 | Targeting mutant KRAS with CRISPR-Cas9 controls tumor growth
| GENOME RESEARCH |
| 2012 | The efficacy and toxicity of S-1 and cisplatin as first-line chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2022 | The efficacy of immune checkpoint inhibitors in elderly patients: a meta-analysis and meta-regression
| ESMO OPEN |
| 2022 | The presence and size of intrahepatic tumors determine the therapeutic efficacy of nivolumab in advanced hepatocellular carcinoma
| THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY |
| 2019 | Tumour Exosomal CEMIP Protein Promotes Cancer Cell Colonization in Brain Metastasis | NATURE CELL BIOLOGY |
| 2023 | Tumour extracellular vesicles and particles induce liver metabolic dysfunction | NATURE |
| 2017 | Unshielding Exosomal RNA Unleashes Tumor Growth And Metastasis
| CELL |
| 2021 | Upfront chemotherapy and short-course radiotherapy with delayed surgery for locally advanced rectal cancer with synchronous liver metastases | EJSO |
| 2020 | Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial
| TRIALS |
